Dr. Daniel KopansBreastDr. Daniel Kopans: Will the USPSTF heed science on breast screening?The U.S. Preventive Services Task Force (USPSTF) has begun a review of its guidelines on breast screening. Dr. Daniel Kopans believes the task force should heed the established science on mammography and recommend screening of women in their 40s.January 28, 2021BreastKopans: New NEJM paper offers rehash on 'overdiagnosis'In this Second Opinion article, Dr. Daniel Kopans of Massachusetts General Hospital comments on a paper on breast screening by Welch et al published this week in the New England Journal of Medicine. The Welch paper is based on false assumptions and makes the same mistakes as a 2012 paper on the same topic, according to Kopans.October 12, 2016BreastKopans: JAMA Oncology paper misinterprets DCIS dataJust how deadly is ductal carcinoma in situ (DCIS)? A paper by Narod et al published on August 20 in JAMA Oncology suggests that the best way to deal with DCIS is simply to ignore it, rather than treating it aggressively. But such conclusions represent a dangerous misinterpretation of the actual data, according to Dr. Daniel Kopans.August 23, 2015HomeA response to Harding et alThe ploy used by Harding et al in their new study is classic. Explain why using your approach is scientifically unsupportable, and then go ahead and use it claiming there is no alternative.July 5, 2015BreastDr. Daniel Kopans: Topol ignores facts on mammographyIn this Second Opinion article, Dr. Daniel Kopans of Massachusetts General Hospital offers a rebuttal of a May 6 column by cardiologist Dr. Eric Topol that calls for an end to routine mammography screening. Dr. Kopans believes the column misinterprets the facts about breast screening.May 6, 2015BreastDr. Daniel Kopans: On the draft USPSTF breast screening guidelinesIn this Second Opinion article, Dr. Daniel Kopans offers his perspective on the release this week of new guidelines on screening mammography from the U.S. Preventive Services Task Force (USPSTF) -- guidelines that he believes will restrict access to mammography.April 20, 2015BreastKopans: Attacks on mammography are part of coordinated effortIn this Second Opinion article, breast imaging expert Dr. Daniel Kopans of Massachusetts General Hospital offers his perspective on the rising number of research studies with negative findings on screening mammography.April 27, 2014BreastKopans: Breast cancer overdiagnosis grossly exaggeratedIn this Second Opinion article, breast imaging expert Dr. Daniel Kopans offers his rebuttal of a study published last November in the New England Journal of Medicine, which raised questions about the value of screening mammography and claimed that a third of detected breast cancers represent "overdiagnosis."April 29, 2013BreastShock and awe over JAMA editorialThe University of California, San Francisco researchers who authored this week's JAMA editorial on screening have disregarded the facts regarding the value of screening mammography, according to Dr. Daniel Kopans, who shares his view in this AuntMinnie Second Opinion.October 21, 2009BreastDBT: Not a panacea, but promising technology is unfairly pannedThe debate over the relative value of digital breast tomosynthesis (DBT) for cancer screening continues with Dr. Daniel Kopans, founder of the breast imaging division at Massachusetts General Hospital in Boston, who offers an opinion on the technology.October 29, 2007Page 1 of 1Top StoriesCTAR-guided localization may sub for CT for early-stage lung cancerAR-guided localization was noninferior to conventional CT guidance and led to better patient experiences.CTStudy backs LDCT lung cancer screening in SingaporeClinical NewsNew criteria evaluates treatment response in bone metastasesCTCT sign may flag who benefits from subdural hematoma procedureHomeClassification system could improve MRI lumbar spinal stenosis grading
